Drug profile · INN
diclofenac
CLONAC 25
diclofenac (CLONAC 25) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — diclofenac
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 12
- Data quality
- 0.84
Quick answer
diclofenac (CLONAC 25) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is diclofenac?
diclofenac (CLONAC 25) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diclofenac?
CLONAC 25 is a marketed brand name for diclofenac. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diclofenac?
diclofenac has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.